NA
AMYT

NewEdge Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

NewEdge Advisors’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-171
Closed -$1 – 4313
2022
Q4 		$1 Buy
+171
New +$1.21K ﹤0.01% 4069

Other funds holding AMYT

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NewEdge Advisors's AMYT Position: Q1 2023 in Review

NewEdge Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 171 shares — an estimated $1 sold.

NewEdge Advisors first reported a position in AMYT in Q4 2022 and held it in 1 quarter. The position peaked at $1 in Q4 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • NewEdge Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • NewEdge Advisors sold 171 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $1.
  • NewEdge Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • NewEdge Advisors's Amryt Pharma plc American Depositary Shares position peaked at $1 in Q4 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.